Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Contraception
|
October 17, 1998
A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives
U Aden, C Jung-Hoffmann, H Kuhl
Contraception
|
October 1, 1988
Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene
H Kuhl, C Jung-Hoffmann, F Heidt
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
March 1, 1987
Direct radioimmunoassay of free testosterone in the evaluation of androgenetic manifestations in women
C Jung-Hoffmann, H D Taubert, H Kuhl
Contraception
|
October 17, 1998
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters
I Wiegratz, C Jung-Hoffmann, W Gross, et al.
Contraception
|
January 1, 1993
The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters
H Kuhl, C Jung-Hoffmann, J Weber, et al.
Hormone Research
|
January 1, 1995
Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel
H Kuhl, C Jung-Hoffmann, M Fitzner, et al.
Contraception
|
March 1, 1990
Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel
W März, C Jung-Hoffmann, F Heidt, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1990
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives
H Kuhl, W März, C Jung-Hoffmann, et al.
Geburtshilfe Und Frauenheilkunde
|
April 1, 1988
[Effect of 2 low-dosage Gestodene or desogestrel containing ovulation inhibitors on sex hormones and lipid metabolism]
C Jung-Hoffmann, W März, F Heidt, et al.
Contraception
|
January 1, 1993
Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in Lp(a) levels
H Kuhl, W März, C Jung-Hoffmann, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Contraception
|
October 17, 1998
A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives
U Aden, C Jung-Hoffmann, H Kuhl
Contraception
|
October 1, 1988
Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene
H Kuhl, C Jung-Hoffmann, F Heidt
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
March 1, 1987
Direct radioimmunoassay of free testosterone in the evaluation of androgenetic manifestations in women
C Jung-Hoffmann, H D Taubert, H Kuhl
Contraception
|
October 17, 1998
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters
I Wiegratz, C Jung-Hoffmann, W Gross, et al.
Contraception
|
January 1, 1993
The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters
H Kuhl, C Jung-Hoffmann, J Weber, et al.
Hormone Research
|
January 1, 1995
Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel
H Kuhl, C Jung-Hoffmann, M Fitzner, et al.
Contraception
|
March 1, 1990
Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel
W März, C Jung-Hoffmann, F Heidt, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1990
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives
H Kuhl, W März, C Jung-Hoffmann, et al.
Geburtshilfe Und Frauenheilkunde
|
April 1, 1988
[Effect of 2 low-dosage Gestodene or desogestrel containing ovulation inhibitors on sex hormones and lipid metabolism]
C Jung-Hoffmann, W März, F Heidt, et al.
Contraception
|
January 1, 1993
Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in Lp(a) levels
H Kuhl, W März, C Jung-Hoffmann, et al.
Page
of 2